Eagle Global Advisors LLC maintained its stake in shares of Clorox Company (The) (NYSE:CLX) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,726 shares of the company’s stock at the end of the second quarter. Eagle Global Advisors LLC’s holdings in Clorox Company (The) were worth $230,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of CLX. American Beacon Advisors Inc. acquired a new stake in shares of Clorox Company (The) during the first quarter valued at approximately $104,000. Quadrant Capital Group LLC boosted its stake in shares of Clorox Company (The) by 23.0% in the first quarter. Quadrant Capital Group LLC now owns 846 shares of the company’s stock valued at $106,000 after buying an additional 158 shares during the period. Valley National Advisers Inc. boosted its stake in shares of Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock valued at $116,000 after buying an additional 5 shares during the period. Blue Chip Partners Inc. boosted its stake in shares of Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock valued at $122,000 after buying an additional 6 shares during the period. Finally, Zions Bancorporation boosted its stake in shares of Clorox Company (The) by 5.6% in the first quarter. Zions Bancorporation now owns 992 shares of the company’s stock valued at $134,000 after buying an additional 53 shares during the period. Hedge funds and other institutional investors own 70.29% of the company’s stock.

Clorox Company (NYSE CLX) opened at 134.65 on Wednesday. The firm’s 50-day moving average price is $134.34 and its 200 day moving average price is $133.08. The stock has a market cap of $17.34 billion, a PE ratio of 26.60 and a beta of 0.40. Clorox Company has a 1-year low of $111.24 and a 1-year high of $141.76.

Clorox Company (The) (NYSE:CLX) last released its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.04. The company had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.65 billion. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. Clorox Company (The)’s revenue was up 2.9% compared to the same quarter last year. During the same quarter last year, the firm posted $1.30 earnings per share. Equities research analysts expect that Clorox Company will post $5.68 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This news story was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this news story on another site, it was stolen and reposted in violation of United States & international copyright & trademark law. The legal version of this news story can be viewed at https://www.dailypolitical.com/2017/08/09/clorox-company-the-clx-position-held-by-eagle-global-advisors-llc.html.

Several brokerages have commented on CLX. UBS AG reiterated a “sell” rating and issued a $121.00 price target (up from $117.00) on shares of Clorox Company (The) in a research report on Friday, May 5th. BidaskClub raised Clorox Company (The) from a “strong sell” rating to a “sell” rating in a research note on Monday, July 31st. BMO Capital Markets set a $150.00 price target on Clorox Company (The) and gave the stock a “buy” rating in a research note on Thursday, August 3rd. Zacks Investment Research cut Clorox Company (The) from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Finally, Royal Bank Of Canada reissued a “hold” rating and issued a $115.00 price target on shares of Clorox Company (The) in a research note on Wednesday, August 2nd. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $129.13.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.